Back
Ares Dynamic Credit Allocation Fund Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
32
ARDC
Ares Dynamic Credit Allocation Fund
Last Price:
$13.32
Seasonality Move:
2.32%
Sell
46
CRSP
CRISPR Therapeutics AG
Last Price:
$56.69
Seasonality Move:
16.15%
Sell
32
Ares Dynamic Credit Allocation Fund (ARDC)
is a Sell
Is Ares Dynamic Credit Allocation Fund a Buy, Sell or Hold?
-
The current Ares Dynamic Credit Allocation Fund [ARDC] share price is $13.33. The Score for ARDC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
ARDC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $56.68. The Score for CRSP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARDC Stock Price Chart
What is Ares Dynamic Credit Allocation Fund's stock price today?
-
The Ares Dynamic Credit Allocation Fund share price today is $13.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARDC is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $56.68The current trend is moderately bullish and CRSP is experiencing slight selling pressure.
ARDC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 36.5 | Sell |
| Chaikin Money Flow: | -41122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.37 - 13.79) | Sell |
| Bollinger Bands (100): | (13.54 - 14.56) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 50.79 | Buy |
| Chaikin Money Flow: | -310612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.51 - 56.73) | Buy |
| Bollinger Bands (100): | (52.75 - 65.77) | Sell |
ARDC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.41 | Sell |
| 20-day SMA: | 13.5 | Sell |
| 50-day SMA: | 13.59 | Sell |
| 200-day SMA: | 14.03 | Sell |
| 8-day EMA: | 13.41 | Sell |
| 20-day EMA: | 13.5 | Sell |
| 50-day EMA: | 13.68 | Sell |
| 200-day EMA: | 14.09 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.23 | Sell |
| 20-day SMA: | 54.24 | Buy |
| 50-day SMA: | 60.61 | Sell |
| 200-day SMA: | 50.79 | Buy |
| 8-day EMA: | 56.62 | Buy |
| 20-day EMA: | 55.98 | Buy |
| 50-day EMA: | 56.55 | Buy |
| 200-day EMA: | 36.64 | Buy |
Ares Dynamic Credit Allocation Fund Earnings Growth & ARDC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Ares Dynamic Credit Allocation Fund Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||